Deep Dive: Deep Dive Into Influenza Research

Dr. Keipp Talbot discussed with us the currently increasing rate of influenza in the US, as well as the state of research into flu vaccination—a topic which has significant scrutiny right now given the efficacy of COVID-19 vaccines. Among those options for advancing flu vaccines were products designed for older and/or immunocompromised patients, as well as mRNA technology. Additionally, she discussed how, contrary to common belief, flu research may be better informed by sequencing and screening strategies implemented by COVID-19 response—not the other way around.